
News|Articles|July 17, 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?
Advertisement
Advertorial:
The triad of inflammation, neuropathy, and vasculopathy plays a key role in the development and progression of diabetic retinopathy (DR). Dr. Varun Chaudhary and Dr. Patrick Bussfeld, discuss how retinal non-perfusion (RNP) specifically drives disease progression and why it should be explored as a treatment target.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
DEX implant shows benefit across RVO subgroups in real-world retrospective study
2
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
3
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
4
AI-predicted retinal function shows promise in geographic atrophy
5

























